ConCallIQ
Go Pro
TATAELXSI Diversified 2026-04-??

Tata Elxsi Limited — Q4 FY26

Tata Elxsi reported Q4 FY26 revenue of ₹993.8 crore, growing 0.9% QoQ in constant currency, with EBITDA margin improving 130 bps sequentially to 24.6%.

neutral medium
Compare with...
Revenue ₹994 Cr
EBITDA
PAT
EBITDA Margin 24.6% +130bps
Duration
Read Time 1 min read

Financial stats pending filing verification

2-Minute Summary

✦ AI-Generated from Full Transcript

Tata Elxsi reported Q4 FY26 revenue of ₹993.8 crore, growing 0.9% QoQ in constant currency, with EBITDA margin improving 130 bps sequentially to 24.6%. Transportation grew 2% QoQ, driven by OEM wins (now 77% of vertical revenue), while healthcare declined 13.1% due to delayed deal closures. Media & communication grew 5.6% on deal ramp-ups. Management guided for high single-digit growth in FY27 (down from earlier double-digit aspiration), citing geopolitical uncertainty and cautious client spending. Margin trajectory targets 27% exit margin by Q4 FY27 via operational efficiencies and AI adoption. Risk: healthcare recovery may slip further if deal closures continue to delay.

Risks4 trackedTranscriptfull text
Research workspace

Focused Modules

!Risks 4 risks

Risk Intelligence

Healthcare deal delays persist

View Risks →
Transcript Full text

Call Transcript

Full transcript text is available on this route.

Read Transcript →

Quarter Snapshot

Transportation QoQ Growth (CC) 2%
+2% QoQ

Transportation vertical grew 2% QoQ in constant currency, driven by OEM wins.

Healthcare QoQ Growth (CC) -13.1%
-13.1% QoQ

Healthcare declined 13.1% QoQ due to delayed deal closures; management expects recovery in Q1.

Media & Communication QoQ Growth (CC) 5.6%
+5.6% QoQ

Media & communication grew 5.6% QoQ, led by deal ramp-ups and a large multi-year win.

Utilization Rate 73%
~+3pp QoQ

Utilization improved to 73%, with headroom to reach 80%+ before aggressive hiring.

Fast read

Guidance and risk preview

Top guidance FY27 revenue growth: high single-digit

Management expects high single-digit revenue growth for FY27, down from earlier double-digit aspiration, due to geopolitical uncertainty and delaye...

Top risk Healthcare deal delays persist

Healthcare declined 13.1% QoQ due to deals slipping from Q4 to Q1; if closures continue to delay, recovery may be pushed further.

View Risks →